TUMIATTI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 5.980
AS - Asia 5.758
EU - Europa 5.245
AF - Africa 452
SA - Sud America 283
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.726
Nazione #
US - Stati Uniti d'America 5.913
IT - Italia 1.844
VN - Vietnam 1.613
CN - Cina 1.537
SG - Singapore 1.424
GB - Regno Unito 978
DE - Germania 508
HK - Hong Kong 427
SE - Svezia 423
UA - Ucraina 295
FR - Francia 286
IN - India 255
RU - Federazione Russa 226
BR - Brasile 181
CI - Costa d'Avorio 156
IE - Irlanda 136
NL - Olanda 130
TG - Togo 106
JP - Giappone 104
KR - Corea 100
ZA - Sudafrica 88
FI - Finlandia 77
EE - Estonia 73
BG - Bulgaria 46
SC - Seychelles 41
CA - Canada 38
PH - Filippine 35
ES - Italia 33
JO - Giordania 33
AR - Argentina 31
ID - Indonesia 31
TH - Thailandia 31
TR - Turchia 29
BE - Belgio 27
EC - Ecuador 27
PL - Polonia 27
TW - Taiwan 27
HR - Croazia 24
CH - Svizzera 20
MX - Messico 20
BD - Bangladesh 19
GR - Grecia 17
IQ - Iraq 17
PK - Pakistan 14
AT - Austria 13
CO - Colombia 11
MA - Marocco 11
CL - Cile 10
CZ - Repubblica Ceca 10
DK - Danimarca 10
IR - Iran 10
NG - Nigeria 10
EG - Egitto 9
SA - Arabia Saudita 9
LB - Libano 8
MY - Malesia 8
RO - Romania 8
TN - Tunisia 8
PE - Perù 6
PY - Paraguay 6
DZ - Algeria 5
ET - Etiopia 5
VE - Venezuela 5
AL - Albania 4
AU - Australia 4
AZ - Azerbaigian 4
HU - Ungheria 4
IL - Israele 4
MT - Malta 4
PT - Portogallo 4
UZ - Uzbekistan 4
BO - Bolivia 3
CR - Costa Rica 3
KE - Kenya 3
LK - Sri Lanka 3
LT - Lituania 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
EU - Europa 2
HN - Honduras 2
KZ - Kazakistan 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SM - San Marino 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
GT - Guatemala 1
KG - Kirghizistan 1
Totale 17.715
Città #
Singapore 955
Southend 849
Ashburn 573
Fairfield 533
Ho Chi Minh City 408
Hong Kong 400
Hanoi 382
Chandler 378
Santa Clara 359
San Jose 331
Houston 266
Bologna 249
Woodbridge 243
Wilmington 237
Seattle 226
Princeton 203
Ann Arbor 199
Beijing 199
Hefei 197
Jacksonville 197
Cambridge 178
Abidjan 156
Boardman 141
Dublin 136
Lomé 106
Los Angeles 99
Padova 96
Lauterbourg 92
Nanjing 91
Westminster 87
Milan 85
Seoul 78
Tokyo 77
Dallas 72
New York 72
Rome 68
Haiphong 63
Helsinki 60
Jinan 58
Berlin 57
Da Nang 56
Dong Ket 52
Buffalo 50
Shenyang 48
Saint Petersburg 45
Sofia 45
Guangzhou 43
Medford 42
Redmond 41
Munich 40
Cesena 38
Changsha 38
Shanghai 38
Turin 37
Hebei 36
Amman 33
Mülheim 33
Tianjin 31
Nanchang 30
San Diego 30
Biên Hòa 29
Council Bluffs 29
São Paulo 28
Redondo Beach 26
Hải Dương 25
Yubileyny 25
Brussels 24
Frankfurt am Main 24
Redwood City 24
Chicago 23
Falls Church 23
San Giorgio di Piano 23
Forlì 22
Mahé 22
Palermo 22
Rimini 22
Carpi 21
Haikou 21
Hangzhou 21
Naples 20
Zhengzhou 20
London 19
Taiyuan 19
Bengaluru 18
Bremen 18
Can Tho 18
Des Moines 18
Genoa 18
Bari 17
Bến Tre 17
Florence 16
Jiaxing 16
Nha Trang 16
Orem 16
Ravenna 16
Amsterdam 15
Bắc Giang 15
Johannesburg 15
Phoenix 15
Warsaw 15
Totale 10.873
Nome #
Trasportatori di membrana dei farmaci 867
Integrated analytical approaches for the characterization of Spirulina and Chlorella microalgae 397
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 394
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer 333
Bis(7)-tacrine Derivatives as Multitarget-Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities 297
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 289
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 284
Progettazione e sintesi di analoghi rigidi di metoctramina nello studio dei recettori muscarinici 237
Bovine Serum Amine Oxidase and Polyamine Analogues: Chemical Synthesis and Biological Evaluation Integrated with Molecular Docking and 3-D QSAR Studies 230
Cytotoxicity of methoctramine and methoctramine-related polyamines. 228
Progettazione e sintesi di poliammine a potenziale attività antitumorale 226
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF SUSTITUTED NAPHTHALENE IMIDES AND DIIMIDES AS ANTICANCER AGENT 221
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties 208
Safety issues in nutraceutical exploitation of Chlorella vulgaris, Arthrospira Platensis and Scenedesmus sp. microalgae 200
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery? 195
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 193
Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents 193
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 184
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment. 178
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors 178
Design, Synthesis, and biological evaluation of naphtalene diimides derivatives as anticancer agent 177
Study of the cytotoxic effects of the new synthetic isothiocyanate CM9 and its fullerene derivative on human T-leukemia cells 176
Natural polyamines and synthetic analogs modify the growth and the morphology of Pyrus communis pollen tubes affecting ROS levels and causing cell death 175
Novel bis(7)-tacrine derivatives as multitarget ligands: focus on anti-cholinesterase and anti-amyloid activities 173
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 169
Synthetic polyamines activating autophagy: Effects on cancer cell death 168
Macrocyclic naphthalene diimides as G-quadruplex binders 168
NEWLY SYNTHESIZED POLYAMINE DERIVATIVES AS POTENTIAL ANTICANCER AGENTS 167
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and a perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics 165
Exploiting RNA as a new biomolecular target for synthetic polyamines 165
Design, synthesis, and biological evaluation of substituted naphtalene imides and diimides as anticancer agents 164
Multitarget-directed ligands: Innovative chemical probes and therapeutic tools against Alzheimer's disease 163
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 160
Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent 158
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 158
Phenolic and Antioxidant Characterization of Fruit By-Products for Their Nutraceuticals and Dietary Supplements Valorization under a Circular Bio-Economy Approach 157
Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update 155
Synthesis of Monomeric Derivatives To Probe Memoquin's Bivalent Interactions 154
Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines 153
Exploring the effects of isothiocyanates on chemotherapeutic drugs 153
Multifunctional Tacrine Derivatives in Alzheimer’s Disease 152
Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment 151
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate. 150
Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations 149
Preliminary evaluation of the cytotoxicity of naphthalene diimide-polyamine conjugates in human cancer cells 148
One-molecule-multiple-target strategy: a novel multifunctional molecule designed to block EGF-r and to exert pro-apoptotic effects 147
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases 147
Integrated analytical approaches for the characterization of nutraceutical bioactives in microalgae 146
Cytotoxicity of Methoctramine and related Spermine analogues 145
Heterocyclic inhibitors of AChE acylation and peripheral sites. 143
In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockers 143
Structure-Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Futher Investigation on the Inner Spacer. 142
MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond 141
null 141
Analytical characterization of commercial microalgae 139
Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: Effect of replacing the inner polymethylene chain with cyclic moieties 139
Multi-target-directed drug design strategy: quinone derivatives designed to block amyloid-beta aggregation and to exert antioxidant effects 138
Multi-Target-Direcetd Ligands as acetylcholinesterase inhibitors and nicotinic modulators for Alzheimer's disease 137
Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study. 137
Progress in acetylcholinesterase inhibitors for Alzheimer's disease 136
Cytotoxicity of methoctramine-related polyamines 136
null 135
Polymethylene tetraamine backbone as template for the development of biologically active polyamines 134
Structure-Activity Relationships of New Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone 134
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases 134
Methoctramine analogues inhibit responses to capsaicin and protons in rat dorsal root ganglion neurons 131
A rational design of new multi-target-directed-ligands for the treatment of Alzheimer's disease 130
From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease 130
Naphthalene diimide-polyamine hybrids as antiproliferative agents: Focus on the architecture of the polyamine chains 130
Methoctramine-related polyamines as antinociceptive agents 129
Methoctramine analogues inhibit responses to capsaicin in DRG neurons and cloned TRPV1 129
Multi-Target-Directed Drug Design Strategy: Development of new Naphthalene Diimides Bearing Isothiocyanate Functionality As Anticancer Agents 127
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy 127
Discovery of multipotent drugs for the teratment of Alzheimer's disease 125
Synthetic polyamines: an overview of their multiple biological activities. 125
Rational design of multitarget-directed antioxidants: merging memoquin and lipocrine molecular frameworks 125
Recent advances in alpha1-adrenoreceptor antagonists as pharmacological tools and therapeutic agents. 123
Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors 123
Inibitori delle fosfodiesterasi 122
Design of Experiments and Optimization of Monacolin K Green Extraction from Red Yeast Rice by Ultra-High-Performance Liquid Chromatography 120
Polyamines analogs and transglutaminase effects on apical growth of the pollen tube 118
Synthetic polyamines as potential amine oxidases inhibitors: a preliminary study 116
Tacrine Derivatives and Alzheimer's Disease 116
Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionality 115
Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration 113
Effect of polyamines on the nicotinic ACh receptor 113
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases. 112
Exploiting RNA as anticancer target for synthetic polyamines 110
Recent advances in the design and synthesis of prazosin derivatives 110
Methoctramine effects on nicotinic acetylcholine receptor kinetics 109
Polyamines, their analogs, and transglutaminase effects on apical growth of the pollen tube 108
Synthesis of monomeric derivatives to probe Memoquin bivalent interactions 107
null 107
Methoctramine analogues inhibit capsaicin induced currents in dorsal root ganglia and Xenopus oocytes expressing TRPV1 106
null 106
Polyamine effects on apical growth of the pollen tube 105
null 104
Interactions between new polyamine analogs and bovine serum amine oxidase. 103
Novel asymmetric naphthalenediimide-polyamines conjugates as anticancer agents. 101
A kinetic study of new polyamine analogs oxidized by bovine serum amine oxidase . 99
Totale 16.428
Categoria #
all - tutte 47.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.188
Totale 48.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021369 0 0 0 0 0 0 0 0 0 88 74 207
2021/20221.873 109 59 119 134 164 125 53 138 97 193 347 335
2022/20231.891 219 249 89 224 113 119 101 99 334 60 186 98
2023/20241.004 45 112 78 83 83 193 44 88 55 59 86 78
2024/20252.821 152 348 324 213 563 158 195 115 51 114 134 454
2025/20265.659 589 690 518 412 667 310 895 171 1.068 339 0 0
Totale 18.067